These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3010464)

  • 1. Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.
    Sarin PS; Sun DK; Thornton AH; Naylor PH; Goldstein AL
    Science; 1986 May; 232(4754):1135-7. PubMed ID: 3010464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.
    Naylor PH; Naylor CW; Badamchian M; Wada S; Goldstein AL; Wang SS; Sun DK; Thornton AH; Sarin PS
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2951-5. PubMed ID: 2437588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
    Balzarini J; Mitsuya H; De Clercq E; Broder S
    Int J Cancer; 1986 Mar; 37(3):451-7. PubMed ID: 2419266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine.
    Chandra P; Sarin PS
    Arzneimittelforschung; 1986 Feb; 36(2):184-6. PubMed ID: 3008768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.
    Yamamoto JK; Barré-Sinoussi F; Bolton V; Pedersen NC; Gardner MB
    J Interferon Res; 1986 Apr; 6(2):143-52. PubMed ID: 2425014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera.
    Ghrayeb J; Kato I; McKinney S; Huang JJ; Chanda PK; Ho DD; Sarangadharan MG; Chang TW; Chang NT
    DNA; 1986 Apr; 5(2):93-9. PubMed ID: 3011373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAV/HTLV-III gag gene product p24 shares antigenic determinants with equine infectious anemia virus but not with visna virus or caprine arthritis encephalitis virus.
    Goudsmit J; Houwers DJ; Smit L; Nauta IM
    Intervirology; 1986; 26(3):169-73. PubMed ID: 2438251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral chemotherapies directed against HTLV-III/LAV.
    Resnick L
    Mt Sinai J Med; 1986 Dec; 53(8):648-56. PubMed ID: 3027545
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses.
    Benveniste RE; Arthur LO; Tsai CC; Sowder R; Copeland TD; Henderson LE; Oroszlan S
    J Virol; 1986 Nov; 60(2):483-90. PubMed ID: 3021982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
    Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
    Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the discovery of HTLV-III for the treatment of AIDS.
    Yarchoan R; Mitsuya H; Matsushita S; Broder S
    Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.
    Chandra P; Vogel A; Gerber T
    Cancer Res; 1985 Sep; 45(9 Suppl):4677s-4684s. PubMed ID: 2410112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1986 Apr; 83(7):2209-13. PubMed ID: 3008154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.
    Starcich BR; Hahn BH; Shaw GM; McNeely PD; Modrow S; Wolf H; Parks ES; Parks WP; Josephs SF; Gallo RC
    Cell; 1986 Jun; 45(5):637-48. PubMed ID: 2423250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III).
    Sarngadharan MG; Bruch L; Popovic M; Gallo RC
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3481-4. PubMed ID: 2582414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
    Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
    AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
    Harada S; Purtilo DT; Koyanagi Y; Yamamoto N
    Microbiol Immunol; 1986; 30(6):533-44. PubMed ID: 3018457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.